The Moral Injury Symptom Scale-Military Version.

Published

Journal Article

The purpose of this study was to develop a multi-dimensional measure of moral injury symptoms that can be used as a primary outcome measure in intervention studies that target moral injury (MI) in Veterans and Active Duty Military with PTSD. This was a multi-center study of 427 Veterans and Active Duty Military with PTSD symptoms recruited from VA Medical Centers in Augusta, Los Angeles, Durham, Houston, and San Antonio, and from Liberty University in Lynchburg. Internal reliability of the Moral Injury Symptom Scale-Military Version (MISS-M) was examined along with factor analytic, discriminant, and convergent validity. Participants were randomly split into two equal samples, with exploratory factor analysis conducted in the first sample and confirmatory factor analysis in the second. Test-retest reliability was assessed in a subsample of 64 Veterans. The 45-item MISS-M consists of 10 theoretically grounded subscales assessing guilt, shame, moral concerns, religious struggles, loss of religious faith/hope, loss of meaning/purpose, difficulty forgiving, loss of trust, and self-condemnation. The Cronbach's alpha of the overall scale was .92 and of individual subscales ranged from .56 to .91. The test-retest reliability was .91 for the total scale and ranged from .78 to .90 for subscales. Discriminant validity was demonstrated by relatively weak correlations with other psychosocial, religious, and physical health constructs, and convergent validity was indicated by strong correlations with PTSD, depression, and anxiety symptoms. The MISS-M is a reliable and valid multi-dimensional symptom measure of moral injury that can be used in studies targeting MI in Veterans and Active Duty Military with PTSD symptoms and may also be used by clinicians to identify those at risk.

Full Text

Duke Authors

Cited Authors

  • Koenig, HG; Ames, D; Youssef, NA; Oliver, JP; Volk, F; Teng, EJ; Haynes, K; Erickson, ZD; Arnold, I; O'Garo, K; Pearce, M

Published Date

  • February 2018

Published In

Volume / Issue

  • 57 / 1

Start / End Page

  • 249 - 265

PubMed ID

  • 29196962

Pubmed Central ID

  • 29196962

Electronic International Standard Serial Number (EISSN)

  • 1573-6571

Digital Object Identifier (DOI)

  • 10.1007/s10943-017-0531-9

Language

  • eng

Conference Location

  • United States